APO RESEARCH · REPORT
Fosfomycin Trometamol
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Product & engineering
Understand the product.
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Selected research
Market Analysis & Forecast
Global Fosfomycin Trometamol Market Analysis and Forecast 2026-2032
Market perspective
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Global Fosfomycin Trometamol key players include Zambon, Northesat Pharm, Hunan Huana Pharmaceuticals, etc. Global top three manufacturers hold a share over 60%.
Read the full market overview
China is the largest market, with a share over 60%, followed by Europe, with a share over 30 percent.
In terms of product, Fosfomycin Tromethamine Granules is the largest segment, with a share over 55%. And in terms of application, the largest application is Common Urinary Tract Infection, followed by Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection, etc.
This report presents an overview of global market for Fosfomycin Trometamol, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Fosfomycin Trometamol, also provides the consumption of main regions and countries. Of the upcoming market potential for Fosfomycin Trometamol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fosfomycin Trometamol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fosfomycin Trometamol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Fosfomycin Trometamol sales, projected growth trends, production technology, application and end-user industry.
Fosfomycin Trometamol Segment by Company
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun
Fosfomycin Trometamol Segment by Type
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Fosfomycin Trometamol Segment by Application
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection
Others
Fosfomycin Trometamol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Trometamol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Trometamol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Trometamol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Fosfomycin Trometamol production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Fosfomycin Trometamol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Fosfomycin Trometamol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fosfomycin Trometamol sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fosfomycin Tromethamine Granules
- Fosfomycin Tromethamine Powder
Applications
- Common Urinary Tract Infection
- Postoperative Urinary Tract Infection
- Preoperative Prevention of Urinary Tract Infection
- Others
Companies covered
- Zambon
- Northesat Pharm
- Hunan Huana Pharmaceuticals
- Xunda Pharma
- FarmaSino Pharmaceutical
- Guilin Hwasun
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Fosfomycin Trometamol Market by Type
- 1.2.1 Global Fosfomycin Trometamol Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Fosfomycin Tromethamine Granules
- 1.2.3 Fosfomycin Tromethamine Powder
- 1.3 Fosfomycin Trometamol Market by Application
- 1.3.1 Global Fosfomycin Trometamol Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Common Urinary Tract Infection
- 1.3.3 Postoperative Urinary Tract Infection
- 1.3.4 Preoperative Prevention of Urinary Tract Infection
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Fosfomycin Trometamol Market Dynamics
- 2.1 Fosfomycin Trometamol Industry Trends
- 2.2 Fosfomycin Trometamol Industry Drivers
- 2.3 Fosfomycin Trometamol Industry Opportunities and Challenges
- 2.4 Fosfomycin Trometamol Industry Restraints
3 Global Fosfomycin Trometamol Production Overview
- 3.1 Global Fosfomycin Trometamol Production Capacity (2021-2032)
- 3.2 Global Fosfomycin Trometamol Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Fosfomycin Trometamol Production by Region
- 3.3.1 Global Fosfomycin Trometamol Production by Region (2021-2026)
- 3.3.2 Global Fosfomycin Trometamol Production by Region (2027-2032)
- 3.3.3 Global Fosfomycin Trometamol Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global Fosfomycin Trometamol Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Fosfomycin Trometamol Revenue by Region
- 4.2.1 Global Fosfomycin Trometamol Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Fosfomycin Trometamol Revenue by Region (2021-2026)
- 4.2.3 Global Fosfomycin Trometamol Revenue by Region (2027-2032)
- 4.2.4 Global Fosfomycin Trometamol Revenue Market Share by Region (2021-2032)
- 4.3 Global Fosfomycin Trometamol Sales Estimates and Forecasts 2021-2032
- 4.4 Global Fosfomycin Trometamol Sales by Region
- 4.4.1 Global Fosfomycin Trometamol Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Fosfomycin Trometamol Sales by Region (2021-2026)
- 4.4.3 Global Fosfomycin Trometamol Sales by Region (2027-2032)
- 4.4.4 Global Fosfomycin Trometamol Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Fosfomycin Trometamol Revenue by Manufacturers
- 5.1.1 Global Fosfomycin Trometamol Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Fosfomycin Trometamol Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Fosfomycin Trometamol Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Fosfomycin Trometamol Sales by Manufacturers
- 5.2.1 Global Fosfomycin Trometamol Sales by Manufacturers (2021-2026)
- 5.2.2 Global Fosfomycin Trometamol Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Fosfomycin Trometamol Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Fosfomycin Trometamol Sales Price by Manufacturers (2021-2026)
- 5.4 Global Fosfomycin Trometamol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Fosfomycin Trometamol Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Fosfomycin Trometamol Manufacturers, Product Type & Application
- 5.7 Global Fosfomycin Trometamol Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Fosfomycin Trometamol Market CR5 and HHI
- 5.8.2 2025 Fosfomycin Trometamol Tier 1, Tier 2, and Tier 3
6 Fosfomycin Trometamol Market by Type
- 6.1 Global Fosfomycin Trometamol Revenue by Type
- 6.1.1 Global Fosfomycin Trometamol Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Fosfomycin Trometamol Revenue Market Share by Type (2021-2032)
- 6.2 Global Fosfomycin Trometamol Sales by Type
- 6.2.1 Global Fosfomycin Trometamol Sales by Type (2021-2032) & (MT)
- 6.2.2 Global Fosfomycin Trometamol Sales Market Share by Type (2021-2032)
- 6.3 Global Fosfomycin Trometamol Price by Type
7 Fosfomycin Trometamol Market by Application
- 7.1 Global Fosfomycin Trometamol Revenue by Application
- 7.1.1 Global Fosfomycin Trometamol Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Fosfomycin Trometamol Revenue Market Share by Application (2021-2032)
- 7.2 Global Fosfomycin Trometamol Sales by Application
- 7.2.1 Global Fosfomycin Trometamol Sales by Application (2021-2032) & (MT)
- 7.2.2 Global Fosfomycin Trometamol Sales Market Share by Application (2021-2032)
- 7.3 Global Fosfomycin Trometamol Price by Application
8 Company Profiles
- 8.1 Zambon
- 8.1.1 Zambon Company Information
- 8.1.2 Zambon Business Overview
- 8.1.3 Zambon Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Zambon Fosfomycin Trometamol Product Portfolio
- 8.1.5 Zambon Recent Developments
- 8.2 Northesat Pharm
- 8.2.1 Northesat Pharm Company Information
- 8.2.2 Northesat Pharm Business Overview
- 8.2.3 Northesat Pharm Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Northesat Pharm Fosfomycin Trometamol Product Portfolio
- 8.2.5 Northesat Pharm Recent Developments
- 8.3 Hunan Huana Pharmaceuticals
- 8.3.1 Hunan Huana Pharmaceuticals Company Information
- 8.3.2 Hunan Huana Pharmaceuticals Business Overview
- 8.3.3 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Product Portfolio
- 8.3.5 Hunan Huana Pharmaceuticals Recent Developments
- 8.4 Xunda Pharma
- 8.4.1 Xunda Pharma Company Information
- 8.4.2 Xunda Pharma Business Overview
- 8.4.3 Xunda Pharma Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Xunda Pharma Fosfomycin Trometamol Product Portfolio
- 8.4.5 Xunda Pharma Recent Developments
- 8.5 FarmaSino Pharmaceutical
- 8.5.1 FarmaSino Pharmaceutical Company Information
- 8.5.2 FarmaSino Pharmaceutical Business Overview
- 8.5.3 FarmaSino Pharmaceutical Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 FarmaSino Pharmaceutical Fosfomycin Trometamol Product Portfolio
- 8.5.5 FarmaSino Pharmaceutical Recent Developments
- 8.6 Guilin Hwasun
- 8.6.1 Guilin Hwasun Company Information
- 8.6.2 Guilin Hwasun Business Overview
- 8.6.3 Guilin Hwasun Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Guilin Hwasun Fosfomycin Trometamol Product Portfolio
- 8.6.5 Guilin Hwasun Recent Developments
9 North America
- 9.1 North America Fosfomycin Trometamol Market Size by Type
- 9.1.1 North America Fosfomycin Trometamol Revenue by Type (2021-2032)
- 9.1.2 North America Fosfomycin Trometamol Sales by Type (2021-2032)
- 9.1.3 North America Fosfomycin Trometamol Price by Type (2021-2032)
- 9.2 North America Fosfomycin Trometamol Market Size by Application
- 9.2.1 North America Fosfomycin Trometamol Revenue by Application (2021-2032)
- 9.2.2 North America Fosfomycin Trometamol Sales by Application (2021-2032)
- 9.2.3 North America Fosfomycin Trometamol Price by Application (2021-2032)
- 9.3 North America Fosfomycin Trometamol Market Size by Country
- 9.3.1 North America Fosfomycin Trometamol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Fosfomycin Trometamol Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Fosfomycin Trometamol Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Fosfomycin Trometamol Market Size by Type
- 10.1.1 Europe Fosfomycin Trometamol Revenue by Type (2021-2032)
- 10.1.2 Europe Fosfomycin Trometamol Sales by Type (2021-2032)
- 10.1.3 Europe Fosfomycin Trometamol Price by Type (2021-2032)
- 10.2 Europe Fosfomycin Trometamol Market Size by Application
- 10.2.1 Europe Fosfomycin Trometamol Revenue by Application (2021-2032)
- 10.2.2 Europe Fosfomycin Trometamol Sales by Application (2021-2032)
- 10.2.3 Europe Fosfomycin Trometamol Price by Application (2021-2032)
- 10.3 Europe Fosfomycin Trometamol Market Size by Country
- 10.3.1 Europe Fosfomycin Trometamol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Fosfomycin Trometamol Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Fosfomycin Trometamol Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Fosfomycin Trometamol Market Size by Type
- 11.1.1 China Fosfomycin Trometamol Revenue by Type (2021-2032)
- 11.1.2 China Fosfomycin Trometamol Sales by Type (2021-2032)
- 11.1.3 China Fosfomycin Trometamol Price by Type (2021-2032)
- 11.2 China Fosfomycin Trometamol Market Size by Application
- 11.2.1 China Fosfomycin Trometamol Revenue by Application (2021-2032)
- 11.2.2 China Fosfomycin Trometamol Sales by Application (2021-2032)
- 11.2.3 China Fosfomycin Trometamol Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Fosfomycin Trometamol Market Size by Type
- 12.1.1 Asia Fosfomycin Trometamol Revenue by Type (2021-2032)
- 12.1.2 Asia Fosfomycin Trometamol Sales by Type (2021-2032)
- 12.1.3 Asia Fosfomycin Trometamol Price by Type (2021-2032)
- 12.2 Asia Fosfomycin Trometamol Market Size by Application
- 12.2.1 Asia Fosfomycin Trometamol Revenue by Application (2021-2032)
- 12.2.2 Asia Fosfomycin Trometamol Sales by Application (2021-2032)
- 12.2.3 Asia Fosfomycin Trometamol Price by Application (2021-2032)
- 12.3 Asia Fosfomycin Trometamol Market Size by Country
- 12.3.1 Asia Fosfomycin Trometamol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Fosfomycin Trometamol Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Fosfomycin Trometamol Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Fosfomycin Trometamol Market Size by Type
- 13.1.1 SAMEA Fosfomycin Trometamol Revenue by Type (2021-2032)
- 13.1.2 SAMEA Fosfomycin Trometamol Sales by Type (2021-2032)
- 13.1.3 SAMEA Fosfomycin Trometamol Price by Type (2021-2032)
- 13.2 SAMEA Fosfomycin Trometamol Market Size by Application
- 13.2.1 SAMEA Fosfomycin Trometamol Revenue by Application (2021-2032)
- 13.2.2 SAMEA Fosfomycin Trometamol Sales by Application (2021-2032)
- 13.2.3 SAMEA Fosfomycin Trometamol Price by Application (2021-2032)
- 13.3 SAMEA Fosfomycin Trometamol Market Size by Country
- 13.3.1 SAMEA Fosfomycin Trometamol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Fosfomycin Trometamol Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Fosfomycin Trometamol Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Fosfomycin Trometamol Value Chain Analysis
- 14.1.1 Fosfomycin Trometamol Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Fosfomycin Trometamol Production Mode & Process
- 14.2 Fosfomycin Trometamol Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Fosfomycin Trometamol Distributors
- 14.2.3 Fosfomycin Trometamol Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst